Tumour dose response to the antivascular agent ZD6126 assessed by magnetic resonance imaging.

Br J Cancer · 2003 · PMC2377119 · PMID 12771928

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

ZD6126 induced a decrease in the highly enhancing fraction of GH3 prolactinomas in a dose-dependent manner, and this response was highly significant at 25 and 50 mg kg −1 .

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.